Immunization

The FDA approved a licensure request for Fluzone High-Dose Quadrivalent, Flublok Quadrivalent, and Fluzone Quadrivalent for use in the upcoming 2022-2023 flu season, providing influenza vaccination for adults 65 years of age and older.

Rates of influenza and associated hospitalizations demand late-season vigilance.

Companies, FDA caught unaware by surge in virus cases, leading to shortage of critical items.

At 1 month, a 50-µg booster dose of mRNA-1273.214 had a potent neutralizing antibody response against the Omicron variants in all individuals, regardless of prior infection.

The FDA approved the first vaccine for dengue disease in May 2019.

This is the first RSV vaccination candidate to show clinically meaningful and statistically significant efficacy in adults aged 60 years and older.

Pharmacy and public health have a long history of collaboration during an emergency.

Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.

The survey results come as the ACIP evaluates data to provide guidance for flu vaccines in older adults.

Data show significantly higher geometric mean titer ratios, meeting prespecified endpoints for superiority against the variant.

Vaccinations are a critical preventive vaccinations are a critical preventive health measure and are routinely recommended from an early age. Indeed, the first hepatitis B vaccine in the series can be administered within 12 to 24 hours of birth.

Vaxneuvance is now indicated for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.

Now we must turn our focus to all recommended vaccinations.

Expert emphasizes that it is important to acknowledge the critical role of pharmacists in overcoming barriers to vaccinations.

Pharmacy provided immunization services start with the confidence of the pharmacy team members in each setting.

Priorix can be administered as a first dose, followed by a second dose of Priorix, or as a second dose to those previously administered the first dose of another MMR-containing vaccine.

Research suggests that individuals receiving a vaccine, such as ones from AstraZeneca and Johnson & Johnson, were more vulnerable to infection by new variants.

Health care and public health officials are concerned over the number of missed or declined immunizations, but the pharmacy can play a role in turning this tide.

With more than 80,000 retail and outpatient pharmacy locations, pharmacists are the most accessible health care professionals in the United States.

Even before the COVID-19 pandemic, vaccine hesitancy has been a challenge among adult patient populations.

Quiz questions to assess your knowledge on common symptoms and treatments for Lyme disease.

Four examples of patient care services that pharmacies can implement and why they can be beneficial to a pharmacy’s business model.

Data from the study shows a strong immune response in this age group following this dose, with no new safety signals.

Investigators observe strong immunogenicity profile in study participants aged 5 to 17 years 1 month after the primary vaccination series.

Hogue is the second pharmacist to ever serve on the advisory committee.

The PREVENT-19 study evaluates the immunogenicity and safety of a third dose of NVX-CoV2373 in children aged 12 to 17 years.

ARCT-154 demonstrates 95% efficacy overall for prevention of severe disease, including related deaths.